Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M167Revenue (TTM) $M50.5Net Margin (%)-10.6Altman Z-Score-2.5
Enterprise Value $M152EPS (TTM) $-0.1Operating Margin %-11.0Piotroski F-Score5
P/E(ttm)--Beneish M-Score-3.3Pre-tax Margin (%)-11.0Higher ROA y-yN
Price/Book7.310-y EBITDA Growth Rate %--Quick Ratio2.5Cash flow > EarningsY
Price/Sales3.35-y EBITDA Growth Rate %--Current Ratio2.6Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %-420.0ROA % (ttm)-13.1Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-25.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M41.2ROIC % (ttm)-304.8Gross Margin Increase y-yN

Gurus Latest Trades with CDXS

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

CDXS is held by these investors:



CDXS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Yang Patrick YDirector 2016-11-15Buy10,000$4.83-16.15view
Vivo Ventures Fund VII, L.P.10% Owner 2016-09-08Sell111,600$4.25-4.71view
WOLF DENNIS PDirector 2016-08-29Sell18,000$4.22-4.03view
KELLEY BERNARD JDirector 2016-08-24Sell12,643$4.26-4.93view
Vivo Ventures Fund VII, L.P.10% Owner 2016-08-16Sell86,894$4.25-4.71view
Vivo Ventures Fund VII, L.P.10% Owner 2016-08-04Sell80,000$4.22-4.03view
Lalonde JamesSVP, R&D 2015-11-11Sell9,441$3.5215.06view
Yang Patrick YDirector 2015-09-11Buy10,000$3.4716.71view
KELLEY BERNARD JDirector 2015-09-10Sell5,200$3.4517.39view
Yang Patrick YDirector 2015-08-24Buy10,000$3.845.47view

Quarterly/Annual Reports about CDXS:

News about CDXS:

Articles On GuruFocus.com
Weekly 3-Year Lows Highlight: SEAS, AMTG, AHH, NCTY, CDXS Dec 30 2013 
Weekly CEO Buys Highlight: AKAM, DRC, MDRX, MTG, CDXS Mar 17 2013 
A New Beginning for Codexis? Mar 08 2013 
Weekly CFO Buys Highlight: ASNB, FXCM, CDXS, VTNC, BRS Sep 24 2012 

More From Other Websites
Should Codexis (CDXS) Be On Your Radar Now? Jan 09 2017
Codexis to Offer High-Performance Enzymes for Diagnostics Markets Jan 06 2017
Codexis to Offer High-Performance Enzymes for Diagnostics Markets Jan 06 2017
The Zacks Analyst Blog Highlights: Codexis, EMCORE, Intevac, Organovo Holdings and StarTek Jan 04 2017
Codexis upgraded by Ladenburg Thalmann Jan 04 2017
5 of the Best Stocks Under $10 for 2017 Jan 03 2017
ETFs with exposure to Codexis, Inc. : December 14, 2016 Dec 14 2016
Codexis to Commercially Supply Proprietary Enzyme to Tate & Lyle Dec 06 2016
ETFs with exposure to Codexis, Inc. : December 2, 2016 Dec 02 2016
Codexis Names Pharmaceutical Industry Veteran Bernard J. Kelley Chairman of the Board Dec 01 2016
Codexis Names Pharmaceutical Industry Veteran Bernard J. Kelley Chairman of the Board Dec 01 2016
Codexis, Inc. :CDXS-US: Earnings Analysis: Q3, 2016 By the Numbers : November 23, 2016 Nov 23 2016
CODEXIS INC Financials Nov 17 2016
Edited Transcript of CDXS earnings conference call or presentation 8-Nov-16 9:30pm GMT Nov 09 2016
Codexis Reports Financial Results for the Third Quarter of 2016 Nov 08 2016
CODEXIS INC Files SEC form 8-K, Results of Operations and Financial Condition Nov 08 2016
Codexis to Hold 2016 Third Quarter Conference Call on November 8 Nov 01 2016
CODEXIS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct... Oct 20 2016
Michael Aldridge Joins Codexis as Senior Vice President, Corporate & Strategic Development Oct 17 2016
CODEXIS INC Files SEC form 8-K, Change in Directors or Principal Officers Oct 14 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)